{"product_id":"ai-in-pathology-markets","title":"AI in Pathology Markets 2027–2031","description":"\u003cp\u003e\u003cstrong\u003eAI in Pathology Markets: Market Forecast, Competitive Landscape, Regulation and World Metropolitan Area Market Sizes, 2027–2031\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGlobal forecasts by cancer type, AI function, specimen type, end user and product, for 14 countries and regions and 237 metropolitan areas, with 32 company profiles. Artificial intelligence applied to pathology slides and images: AI algorithms and apps, AI-based tests and lab services, the AI value of digital pathology platforms, and services and data.\u003c\/p\u003e\n\u003cp\u003eSee the \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/AIPATH_1126_Table_of_Contents.pdf?v=1793750123\" title=\"AI in Pathology Markets Table of Contents\" target=\"_blank\" rel=\"noopener\"\u003eTable of Contents\u003c\/a\u003e. GET the \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Free sample\"\u003eFree Sample of this Report\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003eMany organizations subscribe to all or some of our reports. You may already have free access to this report. FIND out \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Contact Us\"\u003eHere\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eOur Take\u003c\/h3\u003e\n\u003cp\u003ePathology is the first wave of AI in diagnostics. Algorithms that once helped pathologists find cancer on the slide now grade it, score biomarkers and predict who will respond to which therapy, from the same H\u0026amp;E slide. The market grows from $810.0 million in 2026 to $1,600.0 million in 2031, at 14.6% a year, as the slide itself becomes a test and the platforms consolidate into the hands of the diagnostics majors.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/AIPATH_Key_Graphic.png?v=1793750122\" alt=\"From finding cancer to predicting it: AI in pathology market by AI function, 2026 vs 2031\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMarket Size 2026:\u003c\/strong\u003e USD $810M   \u003cstrong\u003eMarket Size 2031:\u003c\/strong\u003e USD $1,600M   \u003cstrong\u003eCAGR:\u003c\/strong\u003e 14.6%\u003c\/p\u003e\n\u003ch3\u003eSituation Analysis: what is really happening\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFrom finding cancer to predicting it. \u003c\/strong\u003eBiomarker prediction and prognosis AI rise from 24.0% to 31.0% of the market; Prognosis \u0026amp; Response Prediction grows 21.7% a year.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe slide becomes a test. \u003c\/strong\u003eAI-Based Tests \u0026amp; Lab Services are the fastest-growing product line at 17.6% a year, after the FDA cleared ArteraAI Breast and Tempus launched Paige Predict.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe platforms consolidate. \u003c\/strong\u003eAgilent agreed to acquire Proscia, Roche agreed to acquire PathAI, Grundium bought Visiopharm and AstraZeneca bought Modella AI.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePharma pays for the answer. \u003c\/strong\u003eThe first Phase 3 trial enrolling on an AI-scored biomarker began, and the FDA qualified PathAI's AIM-NASH for MASH drug trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBeyond H\u0026amp;E. \u003c\/strong\u003eMultiplex \u0026amp; Spatial AI grows 28.6% a year, the fastest specimen type, while Breast overtakes Prostate as the largest cancer type by 2031.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePayment is the brake. \u003c\/strong\u003eThe AMA moved whole-slide AI services into Category III codes without national payment, and China grows 23.4% a year, the fastest of any country.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/AIPATH_Test_Shift.png?v=1793750123\" alt=\"The slide becomes a test: AI in pathology market by product, 2026 vs 2031\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003ch3\u003eCompany Analysis: who is positioned, who is exposed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePaige (Tempus AI), PathAI, Ibex, Proscia, Aiforia, Lunit, Waiv and Indica Labs: \u003c\/strong\u003eLeading computational pathology developers and platforms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eArteraAI, Visiopharm, Deep Bio, Mindpeak, Modella AI, Techcyte, Nucleai and Deciphex: \u003c\/strong\u003eSpecialists in AI-based tests, image analysis, generative AI, cytology, spatial biology and pathology services.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoche, Leica Biosystems, Philips, Agilent, Hamamatsu, 3DHISTECH, Hologic and Sectra: \u003c\/strong\u003eScanner, platform and diagnostics majors building AI into digital pathology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAstraZeneca, Quanterix, Bioptimus, CellaVision, Scopio Labs, Labcorp, PreciseDx and Valar Labs: \u003c\/strong\u003ePharma, spatial, foundation-model, bone marrow and laboratory players.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn all, 32 company profiles, each one to two pages with a fact box covering website, headquarters, ownership, revenue, employees and key products.\u003c\/p\u003e\n\u003ch3\u003eQuestions this report answers\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eHow large is the market for AI in pathology, and how fast will it grow?\u003c\/li\u003e\n\u003cli\u003eWhich cancer types, AI functions and specimen types grow fastest?\u003c\/li\u003e\n\u003cli\u003eHow do algorithms and apps, AI-based tests, platforms and services compare?\u003c\/li\u003e\n\u003cli\u003eWhat do FDA, IVDR, the EU AI Act and the new CPT codes mean for pathology AI?\u003c\/li\u003e\n\u003cli\u003eWhat does consolidation mean for independent developers and laboratories?\u003c\/li\u003e\n\u003cli\u003eHow large is each country market, and which metropolitan areas lead?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhat's inside\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e357 pages, 23 chapters, 108 tables and 59 figures\u003c\/li\u003e\n\u003cli\u003eForecasts for 2027–2031 from a 2026 base year, by cancer type, AI function, specimen type, end user and product, for 14 countries and regions\u003c\/li\u003e\n\u003cli\u003eMarket sizes for 237 world metropolitan areas in 2026 and 2031, with the top 30 and fastest-growing metros\u003c\/li\u003e\n\u003cli\u003eCancer types, AI functions and specimen types; end users and business models; foundation models, scanners and data; digital pathology adoption, validation and workflow; IVD – The Big Picture\u003c\/li\u003e\n\u003cli\u003eRegulation and reimbursement; 10 market-moving developments; SWOT, Porter's Five Forces and strategic recommendations\u003c\/li\u003e\n\u003cli\u003e32 company profiles\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/AIPATH_1126_Table_of_Contents.pdf?v=1793750123\" target=\"_blank\" rel=\"noopener\"\u003eDownload the Table of Contents (PDF)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho buys this report\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePathology AI developers: \u003c\/strong\u003esize target segments, plan regulatory and reimbursement routes and assess partners and acquirers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIVD, scanner and platform companies: \u003c\/strong\u003edecide where to build, buy or partner in pathology AI.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePharma and CROs: \u003c\/strong\u003eplan AI-scored biomarkers and companion diagnostics.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLaboratory and pathology leaders, and investors: \u003c\/strong\u003ebenchmark adoption and the business case, and assess consolidation and growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eUse independent research that makes you the expert. Your credit card order sends the report to your inbox instantly. Check all your licensing options, but don't worry: your order is available as a credit if you wish to upgrade.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSee the \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/AIPATH_1126_Table_of_Contents.pdf?v=1793750123\" title=\"AI in Pathology Markets Table of Contents\" target=\"_blank\" rel=\"noopener\"\u003eTable of Contents\u003c\/a\u003e. GET the \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Free sample\"\u003eFree Sample of this Report\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eABOUT THE LEAD AUTHOR\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/Powellcopy_480x480.png?v=1709168834\" alt=\"Greg Powell\" width=\"142\" height=\"177\"\u003e\u003c\/p\u003e\n\u003cp\u003eMr. Greg Powell, B.Sc., M.B.A., is the President of Howe Sound Research. His education includes:\u003c\/p\u003e\n\u003cp\u003eFinance for Senior Executives - \u003cstrong\u003eHarvard Business School\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMarket Research - \u003cstrong\u003eBurke Institute\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eM.B.A. (Finance and Policy) - \u003cstrong\u003eUniversity of British Columbia\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eB.Sc. (Chemistry) - \u003cstrong\u003eUniversity of British Columbia\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHe is an experienced business and clinical professional, co-author of \"The Radioimmunoassay of Angiotensinogen by Antibody Trapping,\" and has worked in laboratory testing and management for over 20 years. He has written HSR's research on artificial intelligence in diagnostics since its first edition and presents HSR's Smart IVD webinars.\u003c\/p\u003e","brand":"Howe Sound Research","offers":[{"title":"Entire Report Single User","offer_id":68327625556081,"sku":null,"price":6995.0,"currency_code":"USD","in_stock":true},{"title":"Entire Report One to Five Users","offer_id":68327625588849,"sku":null,"price":9995.0,"currency_code":"USD","in_stock":true},{"title":"Entire Report Enterprise License","offer_id":68327625621617,"sku":null,"price":13995.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/AIPATH_1126_covercap.png?v=1793750122","url":"https:\/\/www.howesoundresearch.com\/products\/ai-in-pathology-markets","provider":"Howe Sound Research","version":"1.0","type":"link"}